AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: net selling of $16K to $65K in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- -$16K to -$65K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 10 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $160.23
- 52-wk high
- $174.09
- High
- $161.79
- 52-wk low
- $107.28
- Low
- $159.78
- Prev close
- $162.14
- Mkt cap
- $660.33B
- P/E
- 20.7x
- Volume
- 11.00M
- Fwd P/E
- 14.8x
- Beta
- 0.17
- Div yield
- 2.52%
- P/S
- 1.8x
- P/B
- 2.6x
- Profit margin
- +9.1%
- Op margin
- +15.9%
- ROE
- +12.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about XOM filings
Are insiders buying or selling Exxon Mobil Corp (XOM) stock?
Neither. Exxon Mobil Corp (XOM) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded XOM recently?
Rep. James A. Himes (D) sold $15K to $50K on Jul 20, 2026, disclosed 0 days later. Rep. Matthew Robert Van Epps (R) sold $1K to $15K on Jun 16, 2026, disclosed 1 day later. In total, 2 members disclosed 2 XOM trades with trade dates in the last 180 days, filed a median 1 days after trading.
How current is this XOM smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (3)
- QR
Qube Research
$560.5M
bought
- CI
Citadel
$336.4M
added
- SQ
Squarepoint
$195.6M
added
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in XOM right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.3% below what analysts expected.
Earnings per share
$3.68 expected
Reports Oct 30, 2026, in 33 days
Estimates as of Sep 27, 2026
EPS expected
$3.00 to $4.30
Revenue expected
9 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $83.33B | $80.04B | $83.16B | $114.53B |
| Cost of what it sold | $64.65B | $64.92B | $51.80B | $88.89B |
| Gross profit | $18.68B | $15.12B | $31.36B | $25.63B |
| What it spent | ||||
| Sales and admin | $3.03B | $9.43B | $2.68B | $2.48B |
| Other operating costs | $6.47B | -$315.0M | $23.39B | $4.96B |
| Total operating expenses | $9.51B | $9.11B | $26.07B | $7.44B |
| What was left | ||||
| Operating profit | $9.18B | $6.00B | $5.29B | $18.20B |
| Interest on debt | $207.0M | $80.0M | $295.0M | $227.0M |
| Profit before tax | $10.93B | $8.03B | $6.97B | $19.42B |
| Tax | $3.16B | $1.42B | $2.50B | $4.54B |
| Net profit | $7.55B | $6.50B | $4.18B | $14.53B |
| EBITDA | $17.61B | $15.79B | $10.08B | $28.34B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace